Healthcare -
Biotechnology - NASDAQ - US
$ 1.5049
13.2 %
$ 106 M
Market Cap
-2.25
P/E
SLS - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities SLS - SELLAS Life Sciences Group, Inc.
22.3 M
LAST VALUE
35.95%
2 YEAR CAGR
-0.71%
5 YEAR CAGR
-8.78%
10 YEAR CAGR